CARLA DAVIS to Treatment Outcome
This is a "connection" page, showing publications CARLA DAVIS has written about Treatment Outcome.
Connection Strength
0.069
-
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. J Allergy Clin Immunol. 2020 10; 146(4):863-874.
Score: 0.015
-
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019 03 12; 321(10):946-955.
Score: 0.013
-
Efficacy of a 4-Food Elimination Diet for Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1698-1707.e7.
Score: 0.012
-
Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis. J Pediatr Gastroenterol Nutr. 2017 06; 64(6):933-938.
Score: 0.012
-
Esophageal Food Impaction and Eosinophilic Esophagitis: A Retrospective Study, Systematic Review, and Meta-Analysis. Dig Dis Sci. 2015 Nov; 60(11):3181-93.
Score: 0.010
-
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. J Allergy Clin Immunol. 2009 Nov; 124(5):1062-9.e1-4.
Score: 0.007